Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory disease caused by mutations in effectors and regulators of cytotoxicity in cytotoxic T cells (CTL) and natural killer (NK) cells. The complexity of the immune system means that in vivo models are needed to efficiently study diseases like HLH. Mice with defects in the genes known to cause primary HLH (pHLH) are available. However, these mice only develop the characteristic features of HLH after the induction of an immune response (typically through infection with lymphocytic choriomeningitis virus). Nevertheless, murine models have been invaluable for understanding the mechanisms that lead to HLH. For example, the cytotoxic machinery (i.e., the transport of cytotoxic vesicles and the release of granzymes and perforin after membrane fusion) was first characterized in the mouse. Experiments in murine models of pHLH have emphasized the importance of cytotoxic cells, antigen-presenting cells (APC), and cytokines in hyperinflammatory positive feedback loops (e.g., cytokine storms). This knowledge has facilitated the development of treatments for human HLH, some of which are now being tested in the clinic.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blake, J. A., Eppig, J. T., Kadin, J. A., Richardson, J. E., Smith, C. L., Bult, C. J., et al. (2017). Mouse Genome Database (MGD)-2017: Community knowledge resource for the laboratory mouse. Nucleic Acids Research, 45, D723–D729.
Abolins, S., King, E. C., Lazarou, L., Weldon, L., Hughes, L., Drescher, P., et al. (2017). The comparative immunology of wild and laboratory mice, Mus musculus domesticus. Nature Communications, 8, 14811.
Castrop, H. (2010). Genetically modified mice-successes and failures of a widely used technology. Pflugers Archiv, 459, 557–567.
Justice, M. J., Siracusa, L. D., & Stewart, A. F. (2011). Technical approaches for mouse models of human disease. Disease Models & Mechanisms, 4, 305–310.
Gierut, J. J., Jacks, T. E., & Haigis, K. M. (2014). Strategies to achieve conditional gene mutation in mice. Cold Spring Harbor Protocols, 2014, 339–349.
Perlman, R. L. (2016). Mouse models of human disease: An evolutionary perspective. Evolution, Medicine and Public Health, 2016(1), 170–176.
Henter, J.-I., Horne, A., Aricó, M., Egeler, R. M., Filipovich, A. H., Imashuku, S., et al. (2007). HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer, 48, 124–131.
Doran, A. G., Wong, K., Flint, J., Adams, D. J., Hunter, K. W., & Keane, T. M. (2016). Deep genome sequencing and variation analysis of 13 inbred mouse strains defines candidate phenotypic alleles, private variation and homozygous truncating mutations. Genome Biology, 17, 167.
Sellers, R. S., Clifford, C. B., Treuting, P. M., & Brayton, C. (2012). Immunological variation between inbred laboratory mouse strains. Veterinary Pathology, 49, 32–43.
Eppig, J. T., Motenko, H., Richardson, J. E., Richards-Smith, B., & Smith, C. L. (2015). The International Mouse Strain Resource (IMSR): Cataloging worldwide mouse and ES cell line resources. Mammalian Genome, 26, 448–455.
Brisse, E., Wouters, C. H., & Matthys, P. (2015). Hemophagocytic lymphohistiocytosis (HLH): A heterogeneous spectrum of cytokine-driven immune disorders. Cytokine & Growth Factor Reviews, 26, 263–280.
Kägi, D., Ledermann, B., Bürki, K., Seiler, P., Odermatt, B., Olsen, K. J., et al. (1994). Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature, 369, 31–37.
Walsh, C. M., Matloubian, M., Liu, C. C., Ueda, R., Kurahara, C. G., Christensen, J. L., et al. (1994). Immune function in mice lacking the perforin gene. Proceedings of the National Academy of Sciences of the United States of America, 91, 10854–10858.
Stepp, S. E., Dufourcq-Lagelouse, R., Le Deist, F., Bhawan, S., Certain, S., Mathew, P. A., et al. (1999). Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science, 286(5446), 1957–1959. https://www.ncbi.nlm.nih.gov/pubmed/10583959
Jordan, M. B. (2004). An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood, 104, 735–743.
Badovinac, V. P., Hamilton, S. E., & Harty, J. T. (2003). Viral infection results in massive CD8+ T cell expansion and mortality in vaccinated perforin-deficient mice. Immunity, 18, 463–474.
Lowin, B., Beermann, F., Schmidt, A., & Tschopp, J. (1994). A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proceedings of National Academy of Sciences of United States of America, 91, 11571–11575.
Lowin, B., Hahne, M., Mattmann, C., & Tschopp, J. (1994). Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature, 370, 650–652.
Spielman, J., Lee, R. K., & Podack, E. R. (1998). Perforin/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis. Journal of Immunology, 161, 7063–7070.
van den Broek, M. E., Kägi, D., Ossendorp, F., Toes, R., Vamvakas, S., Lutz, W. K., et al. (1996). Decreased tumor surveillance in perforin-deficient mice. The Journal of Experimental Medicine, 184, 1781–1790.
Kägi, D., Odermatt, B., Seiler, P., Zinkernagel, R. M., Mak, T. W., & Hengartner, H. (1997). Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. The Journal of Experimental Medicine, 186, 989–997.
Müllbacher, A., Hla, R. T., Museteanu, C., & Simon, M. M. (1999). Perforin is essential for control of ectromelia virus but not related poxviruses in mice. Journal of Virology, 73, 1665–1667.
Chang, E., Galle, L., Maggs, D., Estes, D. M., & Mitchell, W. J. (2000). Pathogenesis of Herpes simplex virus type 1-induced corneal inflammation in perforin-deficient mice. Journal of Virology, 74, 11832–11840.
van Dommelen, S. L. H., Sumaria, N., Schreiber, R. D., Scalzo, A. A., Smyth, M. J., & Degli-Esposti, M. A. (2006). Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity, 25, 835–848.
Schmidt, N. W., Khanolkar, A., Hancox, L., Heusel, J. W., & Harty, J. T. (2012). Perforin plays an unexpected role in regulating T-cell contraction during prolonged Listeria monocytogenes infection. European Journal of Immunology, 42, 629–640.
Gupta, M., Greer, P., Mahanty, S., Shieh, W.-J., Zaki, S. R., Ahmed, R., et al. (2005). CD8-mediated protection against Ebola virus infection is perforin dependent. Journal of Immunology, 174, 4198–4202.
Wirtz, T., Weber, T., Kracker, S., Sommermann, T., Rajewsky, K., & Yasuda, T. (2016). Mouse model for acute Epstein-Barr virus infection. Proceedings of the National Academy of Sciences of the United States of America, 113, 201616574.
Badovinac, V. P. (2000). Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma. Science, 290, 1354–1357.
Pham, N. L. L., Badovinac, V. P., & Harty, J. T. (2012). Epitope specificity of memory CD8+ T cells dictates vaccination-induced mortality in LCMV-infected perforin-deficient mice. European Journal of Immunology, 42, 1488–1499.
Yang, J., Huck, S. P., McHugh, R. S., Hermans, I. F., & Ronchese, F. (2006). Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo. Proceedings of the National Academy of Sciences of the United States of America, 103, 147–152.
Terrell, C. E., & Jordan, M. B. (2013). Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells. Blood, 121, 5184–5191.
Jordan, M. B., Hildeman, D., Kappler, J., & Marrack, P. (2004). An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood, 104, 735–743.
Terrell, C. E., & Jordan, M. B. (2013). Mixed hematopoietic or T-cell chimerism above a minimal threshold restores perforin-dependent immune regulation in perforin-deficient mice. Blood, 122, 2618–2621.
Waggoner, S. N., Taniguchi, R. T., Mathew, P. A., Kumar, V., & Welsh, R. M. (2010). Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis. The Journal of Clinical Investigation, 120, 1925–1938.
Lang, P. A., Lang, K. S., Xu, H. C., Grusdat, M., Parish, I. A., Recher, M., et al. (2012). Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proceedings of the National Academy of Sciences o the United States of America, 109, 1210–1215.
Ge, M. Q., Ho, A. W., Tang, Y., Wong, K. H. S., Chua, B. Y. L., Gasser, S., et al. (2012). NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-γ and perforin-dependent mechanisms. Journal of Immunology, 189, 2099–2109.
Zangi, L., Klionsky, Y. Z., Yarimi, L., Bachar-Lustig, E., Eidelstein, Y., Shezen, E., et al. (2012). Deletion of cognate CD8 T cells by immature dendritic cells: A novel role for perforin, granzyme A, TREM-1, and TLR7. Blood, 120, 1647–1657.
Sepulveda, F. E., Maschalidi, S., Vosshenrich, C. A. J., Garrigue, A., Kurowska, M., Menasche, G., et al. (2015). A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice. Blood, 125, 1427–1434.
Waggoner, S. N., & Kumar, V. (2012). Evolving role of 2B4/CD244 in T and NK cell responses during virus infection. Frontiers in Immunology, 3, 377.
Madera, S., Rapp, M., Firth, M. A., Beilke, J. N., Lanier, L. L., & Sun, J. C. (2016). Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20150712
Crouse, J., Bedenikovic, G., Wiesel, M., Ibberson, M., Xenarios, I., VonLaer, D., et al. (2014). Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. Immunity, 40, 961–973.
Xu, H. C., Grusdat, M., Pandyra, A. A., Polz, R., Huang, J., Sharma, P., et al. (2014). Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity. Immunity, 40, 949–960.
Jenkins, M. R., Rudd-Schmidt, J. A., Lopez, J. A., Ramsbottom, K. M., Mannering, S. I., Andrews, D. M., et al. (2015). Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. The Journal of Experimental Medicine, 212, 307–317.
Binder, D., van den Broek, M. F., Kägi, D., Bluethmann, H., Fehr, J., Hengartner, H., et al. (1998). Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus. The Journal of Experimental Medicine, 187, 1903–1920.
Pachlopnik-Schmid, J., Ho, C.-H., Chrétien, F., Lefebvre, J. M., Pivert, G., Kosco-Vilbois, M., et al. (2009). Neutralization of IFNγ defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice. EMBO Molecular Medicine, 1, 112–124.
Rood, J. E., Rao, S., Paessler, M., Kreiger, P. A., Chu, N., Stelekati, E., et al. (2016). ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice. Blood, 127, 426–435.
Humblet-Baron, S., Franckaert, D., Dooley, J., Bornschein, S., Cauwe, B., Schönefeldt, S., et al. (2016). IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis. The Journal of Allergy and Clinical Immunology, 138, 200–209.e8.
Das, R., Guan, P., Sprague, L., Verbist, K., Tedrick, P., An, Q. A., et al. (2016). Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis. Blood, 127, 1666–1675.
Maschalidi, S., Sepulveda, F. E., Garrigue, A., Fischer, A., & de Saint Basile, G. (2016). Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice. Blood, 128, 60–71.
Crozat, K., Georgel, P., Rutschmann, S., Mann, N., Du, X., Hoebe, K., et al. (2006). Analysis of the MCMV resistome by ENU mutagenesis. Mammalian Genome, 17, 398–406.
Crozat, K., Hoebe, K., Ugolini, S., Hong, N. A., Janssen, E., Rutschmann, S., et al. (2007). Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: A mouse model of type 3 familial hemophagocytic lymphohistiocytosis. The Journal of Experimental Medicine, 204, 853–863.
Krebs, P., Crozat, K., Popkin, D., Oldstone, M. B., & Beutler, B. (2011). Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice. Blood, 117, 6582–6588.
Monfregola, J., Johnson, J. L., Meijler, M. M., Napolitano, G., & Catz, S. D. (2012). MUNC13-4 protein regulates the oxidative response and is essential for phagosomal maturation and bacterial killing in neutrophils. The Journal of Biological Chemistry, 287, 44603–44618.
He, J., Johnson, J. L., Monfregola, J., Ramadass, M., Pestonjamasp, K., Napolitano, G., et al. (2016). Munc13-4 interacts with syntaxin 7 and regulates late endosomal maturation, endosomal signaling, and TLR9-initiated cellular responses. Molecular Biology of the Cell, 27, 572–587.
Johnson, J. L., He, J., Ramadass, M., Pestonjamasp, K., Kiosses, W. B., Zhang, J., et al. (2016). Munc13-4 is a Rab11-binding protein that regulates Rab11-positive vesicle trafficking and docking at the plasma membrane. The Journal of Biological Chemistry, 291, 3423–3438.
Chicka, M. C., Ren, Q., Richards, D., Hellman, L. M., Zhang, J., Fried, M. G., et al. (2016). Role of Munc13-4 as a Ca2+-dependent tether during platelet secretion. The Biochemical Journal, 473, 627–639.
D’Orlando, O., Zhao, F., Kasper, B., Orinska, Z., Müller, J., Hermans-Borgmeyer, I., et al. (2013). Syntaxin 11 is required for NK and CD8+ T-cell cytotoxicity and neutrophil degranulation. European Journal of Immunology, 43, 194–208.
Kogl, T., Muller, J., Jessen, B., Schmitt-Graeff, A., Janka, G., Ehl, S., et al. (2013). Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease. Blood, 121, 604–613.
Sepulveda, F. E., Debeurme, F., Ménasché, G., Kurowska, M., Côte, M., Schmid, J. P., et al. (2013). Distinct severity of HLH in both human and murine mutants with complete loss of cytotoxic effector PRF1, RAB27A, and STX11. Blood, 121, 595–603.
Prekeris, R., Klumperman, J., & Scheller, R. H. (2000). Syntaxin 11 is an atypical SNARE abundant in the immune system. European Journal of Cell Biology, 79, 771–780.
Ye, S., Karim, Z. A., Al Hawas, R., Pessin, J. E., Filipovich, A. H., & Whiteheart, S. W. (2012). Syntaxin-11, but not syntaxin-2 or syntaxin-4, is required for platelet secretion. Blood, 120, 2484–2492.
Zhang, S., Ma, D., Wang, X., Celkan, T., Nordenskjöld, M., Henter, J. I., et al. (2008). Syntaxin-11 is expressed in primary human monocytes/macrophages and acts as a negative regulator of macrophage engulfment of apoptotic cells and IgG-opsonized target cells. British Journal of Haematology, 142, 469–479.
Kim, K., Petrova, Y. M., Scott, B. L., Nigam, R., Agrawal, A., Evans, C. M., et al. (2012). Munc18b is an essential gene in mice whose expression is limiting for secretion by airway epithelial and mast cells. The Biochemical Journal, 446, 383–394.
Spessott, W. A., Sanmillan, M. L., McCormick, M. E., Patel, N., Villanueva, J., Zhang, K., et al. (2015). Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion. Blood, 125, 1566–1577.
Silvers, W. K. (1979). The coat colors of mice. New York: Springer.
Wilson, S. M., Yip, R., Swing, D. A., O’Sullivan, T. N., Zhang, Y., Novak, E. K., et al. (2000). A mutation in Rab27a causes the vesicle transport defects observed in ashen mice. Proceedings of the National Academy of Sciences of the United States of America, 97, 7933–7938.
Stinchcombe, J. C., Barral, D. C., Mules, E. H., Booth, S., Hume, A. N., Machesky, L. M., et al. (2001). Rab27a is required for regulating secretion in cytotoxic T lymphocytes. The Journal of Cell Biology, 152, 825–833.
Novak, E. K., Gautam, R., Reddington, M., Collinson, L. M., Copeland, N. G., Jenkins, N. A., et al. (2002). The regulation of platelet-dense granules by Rab27a in the ashen mouse, a model of Hermansky-Pudlak and Griscelli syndromes, is granule-specific and dependent on genetic background. Blood, 100, 128–135.
Pachlopnik Schmid, J., Ho, C.-H., Diana, J., Pivert, G., Lehuen, A., Geissmann, F., et al. (2008). A Griscelli syndrome type 2 murine model of hemophagocytic lymphohistiocytosis (HLH). European Journal of Immunology, 38, 3219–3225.
Johnson, J. L., Hong, H., Monfregola, J., & Catz, S. D. (2011). Increased survival and reduced neutrophil infiltration of the liver in rab27a- but not munc13-4-deficient mice in lipopolysaccharide-induced systemic inflammation. Infection and Immunity, 79, 3607–3618.
Bennett, J. M., Blume, R. S., & Wolff, S. M. (1969). Characterization and significance of abnormal leukocyte granules in the beige mouse: A possible homologue for Chediak-Higashi Aleutian trait. Translational Research, 73, 235–243.
Oliver, C., & Essner, E. (1975). Formation of anomalous lysosomes in monocytes, neutrophils, and eosinophils from bone marrow of mice with Chédiak-Higashi syndrome. Laboratory Investigation, 32, 17–27.
Orn, A., Håkansson, E. M., Gidlund, M., Ramstedt, U., Axberg, I., Wigzell, H., et al. (1982). Pigment mutations in the mouse which also affect lysosomal functions lead to suppressed natural killer cell activity. Scandinavian Journal of Immunology, 15, 305–310.
Roder, J., & Duwe, A. (1979). The beige mutation in the mouse selectively impairs natural killer cell function. Nature, 278, 451–453.
Kärre, K., Klein, G. O., Kiessling, R., Klein, G., & Roder, J. C. (1980). Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient mice. Nature, 284, 624–626.
Barbosa, M. D. F. S., Nguyen, Q. A., Tchernev, V. T., Ashley, J. A., Detter, J. C., Blaydes, S. M., et al. (1996). Identification of the homologous beige and Chediak–Higashi syndrome genes. Nature, 382, 262–265.
McGarry, M. P., Reddington, M., Novak, E. K., & Swank, R. T. (1999). Survival and lung pathology of mouse models of Hermansky-Pudlak syndrome and Chediak-Higashi syndrome. Proceedings of the Society for Experimental Biology and Medicine, 220, 162–168.
Jessen, B., Maul-Pavicic, A., Ufheil, H., Vraetz, T., Enders, A., Lehmberg, K., et al. (2011). Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome. Blood, 118, 4620–4629.
Chatterjee, P., Tiwari, R. K., Rath, S., Bal, V., & George, A. (2012). Modulation of antigen presentation and B cell receptor signaling in B cells of beige mice. Journal of Immunology, 188, 2695–2702.
Westphal, A., Cheng, W., Yu, J., Grassl, G., Krautkrämer, M., Holst, O., et al. (2016). Lysosomal trafficking regulator Lyst links membrane trafficking to toll-like receptor–mediated inflammatory responses. Journal of Experimental Medicine, 214, 227.
Balkema, G. W., Mangini, N. J., & Pinto, L. H. (1983). Discrete visual defects in pearl mutant mice. Science, 219, 1085–1087.
Novak, E. K., Hui, S. W., & Swank, R. T. (1984). Platelet storage pool deficiency in mouse pigment mutations associated with seven distinct genetic loci. Blood, 63, 536–544.
Zhen, L., Jiang, S., Feng, L., Bright, N. A., Peden, A. A., Seymour, A. B., et al. (1999). Abnormal expression and subcellular distribution of subunit proteins of the AP-3 adaptor complex lead to platelet storage pool deficiency in the pearl mouse. Blood, 94, 146–155.
Feng, L., Seymour, A. B., Jiang, S., To, A., Peden, A. A., Novak, E. K., et al. (1999). The β3A subunit gene (Ap3b1) of the AP-3 adaptor complex is altered in the mouse hypopigmentation mutant pearl, a model for Hermansky-Pudlak syndrome and night blindness. Human Molecular Genetics, 8, 323–330.
Feng, L., Rigatti, B. W., Novak, E. K., Gorin, M. B., & Swank, R. T. (2000). Genomic structure of the mouse Ap3b1 gene in normal and pearl mice. Genomics, 69, 370–379.
Yang, W., Li, C., Ward, D. M., Kaplan, J., & Mansour, S. L. (2000). Defective organellar membrane protein trafficking in Ap3b1-deficient cells. Journal of Cell Science, 113(Pt 2), 4077–4086.
Swank, R. T., Novak, E. K., McGarry, M. P., Zhang, Y., Li, W., Zhang, Q., et al. (2000). Abnormal vesicular trafficking in mouse models of Hermansky-Pudlak syndrome. Pigment Cell Research, 13(Suppl 8), 59–67.
Cernadas, M., Sugita, M., van der Wel, N., Cao, X., Gumperz, J. E., Maltsev, S., et al. (2003). Lysosomal localization of murine CD1d mediated by AP-3 is necessary for NK T cell development. Journal of Immunology, 171, 4149–4155.
Young, L. R., Borchers, M. T., Allen, H. L., Gibbons, R. S., & McCormack, F. X. (2006). Lung-restricted macrophage activation in the pearl mouse model of Hermansky-Pudlak syndrome. Journal of Immunology, 176, 4361–4368.
Meng, R., Wu, J., Harper, D. C., Wang, Y., Kowalska, M. A., Abrams, C. S., et al. (2015). Defective release of α granule and lysosome contents from platelets in mouse Hermansky-Pudlak syndrome models. Blood, 125, 1623–1632.
Jessen, B., Bode, S. F. N., Ammann, S., Chakravorty, S., Davies, G., Diestelhorst, J., et al. (2013). The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2. Blood, 121, 2943–2951.
Czar, M. J., Kersh, E. N., Mijares, L. A., Lanier, G., Lewis, J., Yap, G., et al. (2001). Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. Proceedings of the National Academy of Sciences of the United States of America, 98, 7449–7454.
Wu, C., Nguyen, K. B., Pien, G. C., Wang, N., Gullo, C., Howie, D., et al. (2001). SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nature Immunology, 2, 410–414.
Crotty, S., Kersh, E. N., Cannons, J., Schwartzberg, P. L., & Ahmed, R. (2003). SAP is required for generating long-term humoral immunity. Nature, 421, 282–287.
Chan, B., Lanyi, A., Song, H. K., Griesbach, J., Simarro-Grande, M., Poy, F., et al. (2003). SAP couples Fyn to SLAM immune receptors. Nature Cell Biology, 5, 155–160.
Latour, S., Roncagalli, R., Chen, R., Bakinowski, M., Shi, X., Schwartzberg, P. L., et al. (2003). Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation. Nature Cell Biology, 5, 149–154.
Qi, H., Cannons, J. L., Klauschen, F., Schwartzberg, P. L., & Germain, R. N. (2008). SAP-controlled T-B cell interactions underlie germinal centre formation. Nature, 455, 764–769.
Veillette, A., Zhang, S., Shi, X., Dong, Z., Davidson, D., & Zhong, M.-C. (2008). SAP expression in T cells, not in B cells, is required for humoral immunity. Proceedings of the National Academy of Sciences of the United States of America, 105, 1273–1278.
Nichols, K. E., Hom, J., Gong, S.-Y., Ganguly, A., Ma, C. S., Cannons, J. L., et al. (2005). Regulation of NKT cell development by SAP, the protein defective in XLP. Nature Medicine, 11, 340–345.
Pasquier, B., Yin, L., Fondanèche, M.-C., Relouzat, F., Bloch-Queyrat, C., Lambert, N., et al. (2005). Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. The Journal of Experimental Medicine, 201, 695–701.
Das, R., Bassiri, H., Guan, P., Wiener, S., Banerjee, P. P., Zhong, M.-C., et al. (2013). The adaptor molecule SAP plays essential roles during invariant NKT cell cytotoxicity and lytic synapse formation. Blood, 121, 3386–3395.
Yin, L., Al-Alem, U., Liang, J., Tong, W.-M., Li, C., Badiali, M., et al. (2003). Mice deficient in the X-linked lymphoproliferative disease gene sap exhibit increased susceptibility to murine gammaherpesvirus-68 and hypo-gammaglobulinemia. Journal of Medical Virology, 71, 446–455.
Crotty, S., McCausland, M. M., Aubert, R. D., Wherry, E. J., & Ahmed, R. (2006). Hypogammaglobulinemia and exacerbated CD8 T-cell-mediated immunopathology in SAP-deficient mice with chronic LCMV infection mimics human XLP disease. Blood, 108, 3085–3093.
Dong, Z., Davidson, D., Pérez-Quintero, L. A., Kurosaki, T., Swat, W., & Veillette, A. (2012). The adaptor SAP controls NK cell activation by regulating the enzymes Vav-1 and SHIP-1 and by enhancing conjugates with target cells. Immunity, 36, 974–985.
Rivat, C., Booth, C., Alonso-ferrero, M., Blundell, M., Sebire, N. J., Adrian, J., et al. (2013). Murine model of X-linked lymphoproliferative disease. Brief report SAP gene transfer restores cellular and humoral immune function in a murine model of X-linked lymphoproliferative disease. Blood, 121, 1073–1076.
Ruffo, E., Malacarne, V., Larsen, S. E., Das, R., Patrussi, L., Wülfing, C., et al. (2016). Inhibition of diacylglycerol kinase α restores restimulation-induced cell death and reduces immunopathology in XLP-1. Science Translational Medicine, 8, 321ra7.
Harlin, H., Harlin, H., Reffey, S. B., Reffey, S. B., Duckett, C. S., Duckett, C. S., et al. (2001). Characterization of XIAP-de cient mice. Molecular and Cellular Biology, 21, 3604–3608.
Olayioye, M. A., Kaufmann, H., Pakusch, M., Vaux, D. L., Lindeman, G. J., & Visvader, J. E. (2005). XIAP-deficiency leads to delayed lobuloalveolar development in the mammary gland. Cell Death and Differentiation, 12, 87–90.
Bauler, L. D., Duckett, C. S., & O’Riordan, M. X. D. (2008). XIAP regulates cytosol-specific innate immunity to listeria infection. PLoS Pathogens, 4, e1000142.
Rumble, J. M., Bertrand, M. J., Csomos, R. A., Wright, C. W., Albert, L., Mak, T. W., et al. (2008). Apoptotic sensitivity of murine IAP-deficient cells. The Biochemical Journal, 415, 21–25.
Schile, A. J., García-Fernández, M., & Steller, H. (2008). Regulation of apoptosis by XIAP ubiquitin-ligase activity. Genes & Development, 22, 2256–2266.
Jost, P. J., Grabow, S., Gray, D., McKenzie, M. D., Nachbur, U., Huang, D. C. S., et al. (2009). XIAP discriminates between type I and type II FAS-induced apoptosis. Nature, 460, 1035–1039.
Prakash, H., Albrecht, M., Becker, D., Kuhlmann, T., & Rudel, T. (2010). Deficiency of XIAP leads to sensitization for Chlamydophila pneumoniae pulmonary infection and dysregulation of innate immune response in mice. The Journal of Biological Chemistry, 285, 20291–20302.
Fuchs, Y., Brown, S., Gorenc, T., Rodriguez, J., Fuchs, E., & Steller, H. (2013). Sept4/ARTS regulates stem cell apoptosis and skin regeneration. Science, 341, 286–289.
Unsain, N., Higgins, J. M., Parker, K. N., Johnstone, A. D., & Barker, P. A. (2013). XIAP regulates caspase activity in degenerating axons. Cell Reports, 4, 751–763.
Yabal, M., Müller, N., Adler, H., Knies, N., Groß, C. J., Damgaard, R., et al. (2014). XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. Cell Reports, 7, 1796–1808.
Andree, M., Seeger, J. M., Schüll, S., Coutelle, O., Wagner-Stippich, D., Wiegmann, K., et al. (2014). BID-dependent release of mitochondrial SMAC dampens XIAP-mediated immunity against Shigella. The EMBO Journal, 33, 2171–2187.
Hsieh, W.-C., Chuang, Y.-T., Chiang, I., Hsu, S.-C., Miaw, S.-C., & Lai, M.-Z. (2014). Inability to resolve specific infection generates innate immunodeficiency syndrome in Xiap−/− mice. Blood, 124, 2847–2857.
Gentle, I. E., Moelter, I., Lechler, N., Bambach, S., Vucikuja, S., Häcker, G., et al. (2013). Inhibitor of apoptosis proteins (IAPs) are required for effective T cell expansion/survival during anti-viral immunity in mice. Blood, 123, 659–669.
Ebert, G., Preston, S., Allison, C., Cooney, J., Toe, J. G., Stutz, M. D., et al. (2015). Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus. Proceedings of the National Academy of Sciences of the United States of America, 112, 5797–5802.
Gibon, J., Unsain, N., Gamache, K., Thomas, R. A., De Leon, A., Johnstone, A., et al. (2016). The X-linked inhibitor of apoptosis regulates long-term depression and learning rate. The FASEB Journal, 30, 1–8.
Chen, M., Felix, K., & Wang, J. (2012). Critical role for perforin and Fas-dependent killing of dendritic cells in the control of inflammation. Blood, 119, 127–136.
Nansen, A., Jensen, T., Christensen, J. P., Andreasen, S. O., Röpke, C., Marker, O., et al. (1999). Compromised virus control and augmented perforin-mediated immunopathology in IFN-gamma-deficient mice infected with lymphocytic choriomeningitis virus. Journal of Immunology, 163, 6114–6122.
Sepulveda, F. E., Maschalidi, S., Vosshenrich, C. A. J., Garrigue, A., Kurowska, M., Ménasche, G., et al. (2015). A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice. Blood, 125, 1427–1434.
Lykens, J. E., Terrell, C. E., Zoller, E. E., Risma, K., & Jordan, M. B. (2011). Perforin is a critical physiologic regulator of T-cell activation. Blood, 118, 618–626.
Sepulveda, F. E., Garrigue, A., Maschalidi, S., Garfa-Traore, M., Ménasché, G., Fischer, A., et al. (2016). Polygenic mutations in the cytotoxicity pathway increase susceptibility to develop HLH immunopathology in mice. Blood, 127, 2113–2121.
Jessen, B., Kögl, T., Sepulveda, F. E., de Saint Basile, G., Aichele, P., & Ehl, S. (2013). Graded defects in cytotoxicity determine severity of hemophagocytic lymphohistiocytosis in humans and mice. Frontiers in Immunology, 4, 34–36.
Singh, R. K., Mizuno, K., Wasmeier, C., Wavre-Shapton, S. T., Recchi, C., Catz, S. D., et al. (2013). Distinct and opposing roles for Rab27a/Mlph/MyoVa and Rab27b/Munc13-4 in mast cell secretion. The FEBS Journal, 280, 892–903.
Chiossone, L., Audonnet, S., Chetaille, B., Chasson, L., Farnarier, C., Berda-Haddad, Y., et al. (2012). Protection from inflammatory organ damage in a murine model of hemophagocytic lymphohistiocytosis using treatment with IL-18 binding protein. Frontiers in Immunology, 3, 1–10.
Johnson, T. S., Terrell, C. E., Millen, S. H., Katz, J. D., Hildeman, D. A., & Jordan, M. B. (2014). Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis. Journal of Immunology, 192, 84–91.
Booth, C., Carmo, M., & Gaspar, H. B. (2014). Gene therapy for haemophagocytic lymphohistiocytosis. Current Gene Therapy, 14, 437–446.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Volkmer, B., Aichele, P., Pachlopnik Schmid, J. (2019). Murine Models of Familial Cytokine Storm Syndromes. In: Cron, R., Behrens, E. (eds) Cytokine Storm Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-030-22094-5_28
Download citation
DOI: https://doi.org/10.1007/978-3-030-22094-5_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-22093-8
Online ISBN: 978-3-030-22094-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)